Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...
For its annual report "Value Creation in Chemicals 2021 – Ten Years of Steady Growth – and a Few Superstars," the strategy consultancy Boston Consulting Group examined...
The EU Green Deal sets a high bar for reducing greenhouse gas (GHG) emissions, and its impact will be felt across industries. But the chemical sector’s unique nature...
It sometimes seems that everyone running a business always thinks that times are tougher now than they used to be. For producers — and buyers — of commodity chemicals...
Following exclusive negotiations that started last September, German API specialist PharmaZell and French CDMO Novasep have merged as of Apr. 7. The combined group will...
From its inception in 1881, SCI's principal objective has been to further the application of chemistry and related sciences into industry for the public benefit.
The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this...
At an online roundtable event hosted by CHEManager, a group of industry experts discussed the reasons why microreaction technology (MRT) has not achieved the status for...
